Rebecca Reinhard
Physician Assistant · Prosser, WANPI 1073100640
Payments from drug & device makers
Across 64 payments — averaging $32.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$346
- Lilly USA, LLC$290
- Takeda Pharmaceuticals U.S.A., Inc.$284
- Madrigal Pharmaceuticals$208
- Ardelyx, Inc.$157
- Sanofi$95
- plus $683 from 22 others
What the payments were for
- Food & beverage$2,064100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,064 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $41,389 |
| JardianceEmpagliflozin | 26 | $33,396 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $12,566 |
| Bydureon BciseExenatide Microspheres | 11 | $8,177 |
| Aripiprazole | 21 | $2,658 |
| Atorvastatin Calcium | 160 | $2,555 |
| Metoprolol Succinate | 85 | $1,457 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $1,430 |
| Metformin Hcl | 80 | $1,321 |
| Losartan Potassium | 84 | $1,252 |
| Levothyroxine Sodium | 71 | $981 |
| Lisinopril | 94 | $960 |
| Rosuvastatin Calcium | 66 | $888 |
| Metformin Hcl ErMetformin Hcl | 53 | $880 |
| Potassium Chloride | 49 | $824 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $76 | $41,38956 claims |
| Boehringer IngelheimJardiance | $31 | $33,39626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,741 physician assistant providers in Washington.
Other physician assistant in Prosser
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
- Justin ChapinSeattle$40K
- Susan DuffyBellevue$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.